(NASDAQ:ANIK), BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2025 financial results before the opening of the market on Wednesday, November 5, 2025, followed by a conference call at 8:30 a.m. ET […]

(NASDAQ:WSBF), WAUWATOSA, Wis., Oct. 23, 2025 (GLOBE NEWSWIRE) — Waterstone Financial, Inc. (NASDAQ: WSBF), holding company for WaterStone Bank, reported net income of $7.9 million, or $0.45 per diluted share, for the quarter ended September 30, 2025 compared to $4.7 million, or $0.26 per diluted share, for the quarter ended September 30, 2024. Net income

(NASDAQ:CARL), CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its third quarter 2025 financial results after market close on Thursday, November 6, 2025. Management will also host a conference call and concurrent webcast starting at 1:30

(NASDAQ:KNSA), LONDON, Oct. 23, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 28, 2025 at 8:30 a.m. Eastern Time to report its third quarter 2025 financial results and recent portfolio execution. A live webcast will be accessible through

(Brussels:GLPG),(Euronext Amsterdam:GLPG), Mechelen, Belgium; October 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new in vitro pharmacological data from its selective TYK2 inhibitor, GLPG3667, currently in two Phase 3-enabling studies in dermatomyositis (DM) and systemic lupus erythematosus (SLE), at the American College of Rheumatology (ACR) Convergence 2025,

Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 GlobeNewswire October 23, 2025 BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2025 financial results before the opening of

Provident Bancorp, Inc. (the “Company”) (NasdaqCM: PVBC), the holding company for BankProv (the “Bank”), reportednet income for the quarter ended September 30, 2025of $2.7million, or$0.16per diluted share,compared to net income of $2.8million, or $0.17per diluted share, for the quarter endedJune 30, 2025, andnet income of $716,000, or $0.04per diluted share, for the quarter ended September

Analog Devices, Inc.(Nasdaq:ADI)today announced it will release financial results for the fourth quarter fiscal year 2025 at7:00 a.m. Eastern timeonTuesday, November 25, 2025. Following the press release, the Company will host a conference call at10:00 a.m. Eastern time, the same day.Vincent Roche, Chief Executive Officer and Chair,Richard Puccio, Executive Vice President and Chief Financial Officer,

X4 Pharmaceuticals Announces Proposed Underwritten Public Offering GlobeNewswire October 23, 2025 BOSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR) (“X4” or the “Company”), a company driven to improve the lives of people with rare hematology diseases, today announced that it has commenced an underwritten public offering of shares of its common stock

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules GlobeNewswire October 23, 2025 Financing led by Samsara BioCapital, L.P. (“Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds, Invus and Mr. Mir Imran Each of Samsara and Anomaly has the right to designate one